TIROFIBAN (AGGRASTAT) Nursing Considerations

What is the generic name?

TIROFIBAN

What is the Trade Name for TIROFIBAN?

AGGRASTAT

What are the Indications for TIROFIBAN?

• 1 INDICATIONS AND USAGE AGGRASTAT¬Æ is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). AGGRASTAT is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

References: https://open.fda.gov/